JCR Pharmaceuticals Co., Ltd. (4552.T)

Home
4552.T
Financials

661 (JPY) • At close November 8, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Revenue Numbers are in millions	42,871	34,343	51,082	30,085	24,781	23,160	20,594	18,085.035	17,438.377	16,855.654	15,705.912	14,099.91	12,845.064	14,457.846	14,387.4	12,082.718	11,871.886	8,544.735	7,648.819	8,099.74
Cost of Revenue Numbers are in millions	11,620	8,886	10,461	7,812	7,901	6,567	6,128	5,731.719	6,459.424	5,740.928	5,842.081	5,036.939	4,213.016	5,227.348	4,142.465	3,555.732	3,824.724	2,818.303	2,881.399	3,653.64
Gross Profit Numbers are in millions	31,251	25,457	40,621	22,273	16,880	16,593	14,466	12,353.316	10,978.953	11,114.726	9,863.831	9,062.971	8,632.048	9,230.498	10,244.935	8,526.986	8,047.162	5,726.432	4,767.42	4,446.1
Gross Profit Ratio Numbers are in millions	0.729	0.741	0.795	0.74	0.681	0.716	0.702	0.683	0.63	0.659	0.628	0.643	0.672	0.638	0.712	0.706	0.678	0.67	0.623	0.549
Reseach & Development Expenses Numbers are in millions	11,234	8,802	7,175	5,360	5,997	4,354	4,211	4,071.356	3,348.297	3,334	2,202	1,991	0	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	4,992	4,891	4,782	0	0	0	0	0	0	0	0
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	721	1,225	1,139	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	23,719	11,678	13,511	8,624	7,638	7,271	6,470	5,919.956	5,477.886	5,713	6,116	5,921	0	0	0	0	0	0	0	0
Other Expenses Numbers are in millions	5	58	38	61	4	16	10	51.688	107.018	109.726	26.209	22.697	24.803	16.121	128.05	121.703	248.69	-287.857	-199.084	-2,331.354
Operating Expenses Numbers are in millions	23,719	20,480	20,686	14,003	13,635	11,625	10,681	9,991.312	8,826.182	9,100.125	8,318.362	7,912.05	7,542.281	7,822.914	8,237.308	7,980.515	7,765.196	5,890.004	4,802.787	3,986.597
Operating Income Numbers are in millions	7,532	4,975	19,933	8,269	3,244	4,967	3,784	2,362.003	2,152.77	2,014.6	1,545.468	1,150.92	1,089.767	1,407.584	2,007.627	546.471	281.966	-163.572	-35.367	459.503
Operating Income Ratio Numbers are in millions	0.176	0.145	0.39	0.275	0.131	0.214	0.184	0.131	0.123	0.12	0.098	0.082	0.085	0.097	0.14	0.045	0.024	-0.019	-0.005	0.057
Total Other Income Expenses Net Numbers are in millions	-288	434	-532	363	176	-40	111	130.785	306.489	319.711	131.997	-86.131	-147.708	-133.519	-423.682	15.654	154.925	-448.207	74.558	-2,387.26
Income Before Tax Numbers are in millions	7,244	5,412	19,404	8,653	3,422	4,928	3,895	2,492.788	2,459.259	2,334.311	1,677.466	1,064.789	942.059	1,274.065	1,583.945	562.125	436.891	-611.779	39.191	-1,927.757
Income Before Tax Ratio Numbers are in millions	0.169	0.158	0.38	0.288	0.138	0.213	0.189	0.138	0.141	0.138	0.107	0.076	0.073	0.088	0.11	0.047	0.037	-0.072	0.005	-0.238
Income Tax Expense Numbers are in millions	1,707	1,625	4,886	1,764	742	1,217	825	629.517	669.661	651.892	381.133	333.951	308.047	347.508	279.841	21.198	34.382	1,139.593	68.981	-658.989
Net Income Numbers are in millions	5,507	3,772	14,507	6,892	2,678	3,715	3,070	1,863.17	1,789.474	1,682.368	1,296.206	730.715	633.989	926.473	1,302.874	539.911	399.972	-1,751.061	-31.864	-1,272.365
Net Income Ratio Numbers are in millions	0.128	0.11	0.284	0.229	0.108	0.16	0.149	0.103	0.103	0.1	0.083	0.052	0.049	0.064	0.091	0.045	0.034	-0.205	-0.004	-0.157
EPS Numbers are in millions	44.13	30.34	117.26	55.8	21.72	30.17	24.68	14.74	14.03	13.21	10.2	5.76	4.94	7.23	12.69	5.02	3.69	-15.96	-0.5	-16.38
EPS Diluted Numbers are in millions	43.92	30.22	116.79	55.52	21.59	29.99	24.53	14.65	13.95	13.13	10.13	5.73	4.92	7.15	11.39	5.02	3.69	-15.96	-0.5	-16.38
EBITDA Numbers are in millions	10,729	7,479	22,501	10,462	4,749	6,411	5,216	3,945.359	3,729.625	3,586.725	2,836.426	2,185.73	2,164.386	2,347.089	2,673.613	1,399.416	1,159.126	158.637	375.622	-1,316.505
EBITDA Ratio Numbers are in millions	0.25	0.218	0.44	0.348	0.192	0.277	0.253	0.218	0.214	0.213	0.181	0.155	0.168	0.162	0.186	0.116	0.098	0.019	0.049	-0.163

JCR Pharmaceuticals Co., Ltd.

TSE:4552.T Add to watchlist

TSE:4552.T